December 1, 2023
Watch 1 minute
BOSTON — Patients with hepatitis C virus-related cirrhosis who achieve a sustained virological response remain at risk for cancer and other non-liver-related events such as diabetes, according to an abstract presented at a liver meeting.
“We know that hepatitis C has extrahepatic manifestations, and this just reminds us that we really need to continue to monitor these people even after cure,” Nancy S. Reau, MD, FAASLD, AGAF, , chief of the division of hepatology and associate director of organ transplantation at Rush University, told Healio in an interview. “If we hand this over to primary care, we need to make sure there’s enough information in the handover so that these people don’t forget about their liver health.”
Source/Disclosure
collapse
Kanakis J et al. Long-term outcomes after achieving sustained virological response in patients with chronic hepatitis C virus cirrhosis. Published in: Liver Meeting; November 10-14, 2023; Boston (Hybrid Meeting).
Disclosure: Reau said he has served as a consultant to Abbott, AbbVie and Gilead Sciences, and has received funding from AbbVie.
Take Home in HCV